Last Updated: September 24, 2026

COLYTE-FLAVORED Drug Patent Profile

Name: COLYTE-FLAVORED Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Colyte-flavored patents expire, and when can generic versions of Colyte-flavored launch?

Colyte-flavored is a drug marketed by Strides Pharma Intl and is included in one NDA.

The generic ingredient in COLYTE-FLAVORED is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for COLYTE-FLAVORED?
What are the global sales for COLYTE-FLAVORED?
What is Average Wholesale Price for COLYTE-FLAVORED?

Summary for COLYTE-FLAVORED

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	6
DailyMed Link:	COLYTE-FLAVORED at DailyMed

Drug patent expirations by year for COLYTE-FLAVORED

Recent Clinical Trials for COLYTE-FLAVORED

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Incheon St.Mary's Hospital	Phase 3
Seoul National University Hospital	Phase 3
Inje University	N/A

See all COLYTE-FLAVORED clinical trials

US Patents and Regulatory Information for COLYTE-FLAVORED

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma Intl	COLYTE-FLAVORED	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous	FOR SOLUTION;ORAL	018983-008	Nov 14, 1991		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Strides Pharma Intl	COLYTE-FLAVORED	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous	FOR SOLUTION;ORAL	018983-009	Nov 14, 1991		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.